£71.32

This is the usual price. Wait for it to drop, or tell us your number.

£71 today · usual range £50–£73 · best ever £50

Springer Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 57 days · 57 data points (no recent data)

Historical
Generating forecast…
£73.36 £47.54 £53.18 £58.81 £64.44 £70.07 £75.71 01 August 2026 15 August 2026 29 August 2026 12 September 2026 26 September 2026
View at Amazon ↗

Price data last checked 34 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 57 days • 8 price levels

Days at Price
Current Price
15 days 1 day 8 days 3 days 11 days 1 day · current 5 days 13 days 0 4 8 11 15 £50 £58 £61 £64 £67 £71 £72 £73 Days at Price

Price Analysis

Most common price: £50 (15 days, 26.3%)

Price range: £50 - £73

Price levels: 8 different prices over 57 days

Description

Aromatase Inhibitors (AIs) treat postmenopausal estrogen receptor positive tumours, which constitute the majority of breast cancer patients. This comprehensive volume brings together the current knowledge from different relevant areas, including molecular mechanisms and translational aspects of drug resistance in AIs. Topics covered include research, experimental , and clinical data specifically focused on AI resistance in breast cancer. The volume will include three sections. The first section covers general knowledge about aromatase inhibitors, including regulation of aromatase genes, and structure and function of aromatase protein. The second section provides the detailed mechanisms of resistance to AIs, while the third section explores prediction of resistance and potential strategies to overcome resistance. Breast cancer is the most common female cancer and AIs significantly improve treatments outcomes compatibly to previously used endocrine treatments. However 10-15% of post-operative patients develop a relapse during adjuvant treatment with AIs; about 25-50% of the patients do not respond to AIs in neo-adjuvant or metastatic setting, and the majority of metastatic patients who initially respond develop resistance within 3 years. There is an important need to understand these mechanisms of resistance in order to develop methods of preventing or overcoming the resistance to AIs, which will ensure a more successful outcome in treating breast cancer.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
17 October 2016
Listed Since
07 October 2016

Barcode

No barcode data available

Similar Products You Might Like

Aromatase Inhibitors (Milestones in Drug Therapy)
97% match

Aromatase Inhibitors (Milestones in Drug Therapy)

Birkhauser

£83.04 17 Sep 2026
Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)
96% match

Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)

Humana

£56.97 24 Sep 2026
Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer
96% match

Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer

Springer

£109.08 01 Oct 2026
Molecular Mechanisms of Estrogen Action - Springer Symposium
95% match

Molecular Mechanisms of Estrogen Action - Springer Symposium

Springer

£168.43 03 Oct 2026
Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)
95% match

Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER (Cancer Drug Discovery and Development)

Humana

£128.11 21 Aug 2026
Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs
95% match

Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs

Springer

£35.03 24 Sep 2026
Breast Cancer: Methods and Protocols: 1406 (Methods in Molecular Biology, 1406)
95% match

Breast Cancer: Methods and Protocols: 1406 (Methods in Molecular Biology, 1406)

Humana

£81.75 18 Sep 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
95% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£70.04 11 Sep 2026
Molecular Therapy of Breast Cancer: Classicism Meets Modernity (Cancer Etiology, Diagnosis and Treatments Series)
95% match

Molecular Therapy of Breast Cancer: Classicism Meets Modernity (Cancer Etiology, Diagnosis and Treatments Series)

£53.25 11 Sep 2026
Springer Regulatory Mechanisms in Breast Cancer - Book 53
95% match

Springer Regulatory Mechanisms in Breast Cancer - Book 53

Springer

£278.50 21 Aug 2026
Endocrine Therapy of Breast Cancer V (ESO Monographs)
95% match

Endocrine Therapy of Breast Cancer V (ESO Monographs)

Springer

£77.89 21 Sep 2026
Non–Reproductive Actions of Sex Steroids: No. 191 (Novartis Foundation Symposia)
95% match

Non–Reproductive Actions of Sex Steroids: No. 191 (Novartis Foundation Symposia)

Wiley

Price unavailable
Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen: 135 / 2 (Handbook of Experimental Pharmacology, 135 / 2)
95% match

Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen: 135 / 2 (Handbook of Experimental Pharmacology, 135 / 2)

Springer

£72.05 23 Sep 2026
Ein Jahrhundert endokrine Therapie des Mammakarzinoms: Von Beatson bis heute
95% match

Ein Jahrhundert endokrine Therapie des Mammakarzinoms: Von Beatson bis heute

Springer

£46.99 23 Sep 2026
Precision Molecular Pathology of Breast Cancer: 10 (Molecular Pathology Library, 10)
95% match

Precision Molecular Pathology of Breast Cancer: 10 (Molecular Pathology Library, 10)

Springer

£76.94 22 Sep 2026
The Pathobiology of Breast Cancer
95% match

The Pathobiology of Breast Cancer

Springer

£108.01 10 Sep 2026
Post-transcriptional Mechanisms in Endocrine Regulation
95% match

Post-transcriptional Mechanisms in Endocrine Regulation

Springer

£128.45 30 Sep 2026
Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)
95% match

Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)

Springer

£140.72 24 Sep 2026
Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy: Diskussionen zur Postmenopausalen ... Foundation Symposium Proceedings, 13)
95% match

Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy: Diskussionen zur Postmenopausalen ... Foundation Symposium Proceedings, 13)

Springer

£59.83 23 Sep 2026
Advancing Development of Synthetic Gene Regulators: With the Power of High-Throughput Sequencing in Chemical Biology (Springer Theses)
94% match

Advancing Development of Synthetic Gene Regulators: With the Power of High-Throughput Sequencing in Chemical Biology (Springer Theses)

Springer

£76.42 25 Sep 2026
Breast Cancer: Scientific and Clinical Progress: Proceedings of the Biennial Conference for the International Association of Breast Cancer Research, ... 1–5, 1987: 56 (Developments in Oncology, 56)
94% match

Breast Cancer: Scientific and Clinical Progress: Proceedings of the Biennial Conference for the International Association of Breast Cancer Research, ... 1–5, 1987: 56 (Developments in Oncology, 56)

Springer

£145.46 30 Sep 2026